Clinical applications of intravenous immunoglobulins in child neurology.

CONCLUSION: We summarize in this review recent advances in the field of intravenous immunoglobulins use in pediatric neurological diseases. Literature data supports a beneficial effect in this age group. Whilst awaiting the results of large scale studies, administration of intravenous immunoglobulins could be justified in refractory child epilepsy. Otherwise, its use should be guided by the individual needs of each child, depending on the underlying neurological disease. PMID: 28914199 [PubMed - as supplied by publisher]
Source: Epilepsy Curr - Category: Neurology Authors: Tags: Curr Pharm Biotechnol Source Type: research